Slc25a38-KO Mouse
一般名
Slc25a38-KO
製品ID
S-KO-04583
背景情報
C57BL/6NCya
系統ID
KOCMP-208638-Slc25a38-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Slc25a38-KO Mouse(カタログ番号S-KO-04583)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Slc25a38-KO
系統ID
KOCMP-208638-Slc25a38-B6N-VA
遺伝子名
製品ID
S-KO-04583
遺伝子別名
appoptosin
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 9
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000035106
NCBIトランスクリプトID
NM_144793
ターゲット領域
Exon 2~5
有効領域の大きさ
~5.6 kb
遺伝子研究の概要
Slc25a38, a member of the mitochondrial solute carrier family SLC25, is a mitochondrial inner membrane protein. It functions as a glycine carrier [1,4,8,9]. Many proteins require pyridoxal 5'-phosphate (PLP) as a cofactor, and SLC25A38 is involved in mitochondrial PLP accumulation, influencing enzymatic reactions like serine to glycine conversion and ornithine aminotransferase [3]. It is also associated with heme biosynthesis as it supplies mitochondrial glycine for ALAS2 [5].
Mutations in Slc25a38 cause the most common recessive form of congenital sideroblastic anemia (CSA) [1,5,6,8,10]. In a study of 31 individuals from 24 families, 11 novel mutations were identified [1]. In uveal melanoma, low expression of SLC25A38 promotes angiogenesis and metastasis, and is an independent predictive and prognostic factor [2]. In acute lymphoblastic leukemia cells, SLC25A38 is highly expressed and may be a biomarker and therapeutic target [7]. Knock-out of SLC25A38 in UM cells enhanced migration and promoted distant metastasis in mice [2]. Murine models of SLC25A38-CSA showed extreme hypersensitivity to pyridoxine deficiency, uncovering a conditional synthetic lethality between SLC25A38-related CSA and pyridoxine deficiency [5].
In summary, Slc25a38 is crucial for mitochondrial functions, especially in glycine transport and PLP accumulation. Its role in diseases like congenital sideroblastic anemia, uveal melanoma, and acute lymphoblastic leukemia has been revealed through various studies, with murine models providing insights into the pathophysiology and potential therapeutic approaches for SLC25A38-related congenital sideroblastic anemia [1-8,10].
References:
1. Heeney, Matthew M, Berhe, Simon, Campagna, Dean R, Bottomley, Sylvia S, Fleming, Mark D. 2021. SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature. In Human mutation, 42, 1367-1383. doi:10.1002/humu.24267. https://pubmed.ncbi.nlm.nih.gov/34298585/
2. Fan, Zhongyi, Duan, Jingjing, Luo, Pu, Zhang, Lei, Xu, Xiaojie. 2022. SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma. In Cell death & disease, 13, 330. doi:10.1038/s41419-022-04718-8. https://pubmed.ncbi.nlm.nih.gov/35411037/
3. Pena, Izabella A, Shi, Jeffrey S, Chang, Sarah M, Vander Heiden, Matthew G, Heiman, Myriam. 2025. SLC25A38 is required for mitochondrial pyridoxal 5'-phosphate (PLP) accumulation. In Nature communications, 16, 978. doi:10.1038/s41467-025-56130-3. https://pubmed.ncbi.nlm.nih.gov/39856062/
4. Tan, Sijie, Dengler, Alisa Susan, Darawsheh, Rami Zahi, Kory, Nora. 2024. The iAAA-mitochondrial protease YME1L1 regulates the degradation of the short-lived mitochondrial transporter SLC25A38. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.05.12.593764. https://pubmed.ncbi.nlm.nih.gov/38979268/
5. Ducamp, Sarah, Sendamarai, Anoop K, Campagna, Dean R, Schmidt, Paul J, Fleming, Mark D. . Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine. In Blood, 144, 1418-1432. doi:10.1182/blood.2023023078. https://pubmed.ncbi.nlm.nih.gov/38900972/
6. Ravindra, Niveditha, Athiyarath, Rekha, S, Eswari, George, Biju, Edison, Eunice Sindhuvi. 2020. Novel frameshift variant (c.409dupG) in SLC25A38 is a common cause of congenital sideroblastic anaemia in the Indian subcontinent. In Journal of clinical pathology, 74, 157-162. doi:10.1136/jclinpath-2020-206647. https://pubmed.ncbi.nlm.nih.gov/32605921/
7. Chen, Huaying, Lu, Quanyi, Zhang, Yunwu, Zhang, Han, Xu, Huaxi. 2014. Overexpression of SLC25A38 protein on acute lymphoblastic leukemia cells. In Oncology letters, 7, 1422-1426. doi:. https://pubmed.ncbi.nlm.nih.gov/24765149/
8. Kannengiesser, Caroline, Sanchez, Mayka, Sweeney, Marion, Grandchamp, Bernard, May, Alison. 2011. Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia. In Haematologica, 96, 808-13. doi:10.3324/haematol.2010.039164. https://pubmed.ncbi.nlm.nih.gov/21393332/
9. Sha, Zhou, Benkovic, Stephen J. 2024. Purinosomes spatially co-localize with mitochondrial transporters. In The Journal of biological chemistry, 300, 107620. doi:10.1016/j.jbc.2024.107620. https://pubmed.ncbi.nlm.nih.gov/39098527/
10. Andolfo, Immacolata, Martone, Stefania, Ribersani, Michela, Iolascon, Achille, Russo, Roberta. 2020. Apparent recessive inheritance of sideroblastic anemia type 2 due to uniparental isodisomy at the SLC25A38 locus. In Haematologica, 105, 2883-2886. doi:10.3324/haematol.2020.258533. https://pubmed.ncbi.nlm.nih.gov/33256393/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
